PML in HIV 1 Running head : Diffusion imaging of PML in HIV Neuropsychological and neuroimaging outcome of HIV-associated progressive multifocal leukoencephalopathy in the era of ART : a case report

In the present case report we describe the functional outcome of a patient with human immunodeficiency virus (HIV) and progressive multifocal leukoencephalopathy (PML) on treatment with antiretroviral therapy. Neuropsychological tests and structural magnetic resonance imaging were obtained at baseline and again after 12 months to define the severity of white matter damage associated with PML. Diffusion tensor imaging (DTI) was also obtained at the second evaluation to visualize the neuronal damage in the subcortical white matter using region-based analyses and novel scalar metrics based on streamtube tractography. Neuropsychological and neuroimaging data obtained at the 12-month evaluation were compared to an HIV-infected patient without PML and with good immune system health, and to a second HIV-infected patient without PML but with notable immunosuppression. Review of the HIV/PML patient’s cognitive data at both time points revealed significant impairments in domains purportedly subserved by subcortical networks compared to the two control subjects, and a reference group of healthy seronegative controls. Similarly, the HIV/PML patient’s white matter lesion load and whole brain volume were markedly different from the control subjects at both time points. The tractography-defined scalar metrics suggest significant white matter fiber loss associated with HIV/PML that was not evident in either HIV control patient. Our findings suggest that PML is associated with marked cognitive and neuroimaging abnormalities in the context of ART. In addition DTI provides an opportunity to visualize and quantify the degree of white matter damage beyond the capacity of traditional structural imaging.

[1]  Evian Gordon,et al.  Integrative Neuroscience , 2003 .

[2]  E. Bouza,et al.  Treatment of AIDS‐associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy , 1998, AIDS.

[3]  C. Goujard,et al.  Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. , 1999, Journal of neurovirology.

[4]  Brian A. Wandell,et al.  800Exploration of the brain's white matter pathways with dynamic queries , 2004, IEEE Visualization 2004.

[5]  R. DeBiasi,et al.  Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. , 2002, Archives of neurology.

[6]  I. Koralnik Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. , 2002, Journal of neurovirology.

[7]  H. Stellbrink,et al.  Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV‐associated progressive multifocal leukoencephalopathy , 1998, AIDS.

[8]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[9]  J. Mallolas,et al.  Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  E. Gordon,et al.  PRELIMINARY VALIDITY OF “INTEGNEUROTM”: A NEW COMPUTERIZED BATTERY OF NEUROCOGNITIVE TESTS , 2005, The International journal of neuroscience.

[11]  Ronald A. Cohen,et al.  Executive Impairments Predict Functional Declines in Vascular Dementia , 2004, The Clinical neuropsychologist.

[12]  R. D. Du Pasquier,et al.  Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies , 2005, AIDS.

[13]  W. Schlote,et al.  HIV‐Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy , 2002, Journal of acquired immune deficiency syndromes.

[14]  David H. Laidlaw,et al.  Visualizing Diffusion Tensor MR Images Using Streamtubes and Streamsurfaces , 2003, IEEE Trans. Vis. Comput. Graph..

[15]  Ronald A Cohen,et al.  Neurocognitive Manifestations of Human Immunodeficiency Virus , 2002, CNS Spectrums.